PointClickCare Acquires CPSI Subsidiary, American HealthTech


PointClickCare Technologies, a leading healthcare technology platform enabling meaningful collaboration and access to real‐time insights at every stage of the patient healthcare journey, today announced the acquisition of American HealthTech, Inc. (AHT), a subsidiary of Computer Programs and Systems, Inc. and a leading provider of electronic health record (EHR) solutions […]

Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing


Oxford Nanopore Technologies plc, a company providing next-generation nanopore-based molecular sensing technology, and Saphetor, a next-generation sequencing data analysis company, today announce a new partnership to support supports comprehensive analysis of nanopore sequencing data and enables comprehensive analysis of nanopore sequencing data. -end of workflow. The collaboration with Saphetor will […]

Verily and OneOncology Announce Collaboration to Advance Cancer Research


Verily, a precision medical technology company of Alphabet, and OneOncology, the national platform for independent oncology practice, have established a strategic partnership that enables more effective clinical trials. As part of the agreement, Verily will integrate the clinical trial management software (CTMS) platform, SignalPath, with all operations in the OneOncology […]

ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing


ADARx Pharmaceuticals, Inc., a clinical-stage biotech company developing next-generation RNA-based therapies, today announced the successful conclusion of its over-subscribed Series C funding. value of 200 million dollars. The funding was led by Bain Capital Life Science and TCGX and includes new investors Blackrock, Commodore Capital, Cormorant Asset Management, HBM Healthcare […]

Henry Schein Acquires a Majority Interest in Large Practice Sales LLC, a Leading Transaction Advisory Services Business


Henry Schein, Inc., the world’s largest provider of healthcare products and solutions to in-office medical and dental practitioners, today announced the acquisition of controlling interest in Large Practice Sales LLC (LPS), a leading advisor for their independent dental practices. sell or partner with larger general practitioners and dental professionals. Headquartered […]

European Medicines Agency Accepts Astellas’ Marketing Authorization Application for Zolbetuximab


Astella Pharma Inc. announced that the European Medicines Agency (EMA) has accepted regulatory review of the company’s Marketing Authorization (MA) Application for zolbetuximab, an experimental first-class monoclonal antibody targeting Claudin 18.2 (CLDN18.2), for the first-line treatment of patients with locally advanced, unresectable or metastatic gastric or esophageal adenocarcinoma (GEJ) whose […]

KSQ Therapeutics Enters Worldwide License Agreement with Roche for KSQ-4279, a Clinical-Stage USP1 Inhibitor for Cancer


KSQ Therapeutics, Inc., a clinical-stage biotechnology company developing cancer therapies using its proprietary CRISRomics® discovery platform, today announced that it has entered into a worldwide licensing and partnership agreement with Roche to develop and commercialize the KSQ-4279. KSQ-4279 is a selective, potent, first-class small molecule inhibitor of USP1, a protein […]